Table IV.
Estimates of HIV transmission risk resulting from various treatment and prevention modeling assumptions.
Parameters/ modeling assumptions | Number of new infection in 1 year | Rate (1000/year) | Reduction in transmission (%) |
---|---|---|---|
Base model | 2.73 | 23.2 | – |
Correct and consistent condom use (27% base model prevalence) | |||
50% | 1.95 | 16.6 | 0.28 |
75% | 1.08 | 9.1 | 0.61 |
Syphilis (16.7% base model prevalence) | |||
8% | 1.38 | 11.8 | 0.49 |
5% | 0.84 | 7 | 0.70 |
HSV-2 (90% base model prevalence) | |||
45% | 1.35 | 11.7 | 0.50 |
25% | 0.78 | 6.5 | 0.72 |
Male circumcision (31% base model prevalence) | |||
50% | 2.58 | 22.1 | 0.05 |
75% | 2.41 | 20.5 | 0.11 |
Persons on HARRT (base model is 0% adherent) | |||
95% adherent | 1.368 | 12.7 | 0.45 |
80% adherent | 1.152 | 14.5 | 0.38 |
Treatment only | |||
Syphilis & HSV2 (50%) | 0.69 | 5.9 | 0.75 |
Syphilis & HSV2 (50%) | 0.39 | 3.2 | 0.86 |
& HAART (95%) |
Note: The base model parameter estimates listed in parentheses above are based on data among HIV-positive sexually active women and men in Mozambique in the three months prior to initiating highly active antiretroviral therapy.
Syphilis and HSV-2 parameters are based on treatment or suppressive therapy to reduce active sexually transmitted disease prevalence.